ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Yoshinori Handa, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada

Two groups of Clinical Stage IA lung cancer patients were retrospectively investigated. Ninety-nine patients underwent complex segmentectomy, and 94 patients underwent location-adjusted lobectomy. The results of these two different strategies were compared. Outcomes have been comparable regarding mortality, morbidity, overall survival, and recurrence-free survival rates.

 The authors concluded that complex segmentectomy can provide comparable outcomes in Stage IA lung cancer treatment.

Source: World Journal of Critical Care Medicine
Author(s): Massimo Capoccia and Marc O Maybauer

Capoccia and Maybauer performed a system review of 29 publications related to the use of ECMO in aortic surgery and aortic dissection. A total of 194 patients who had been treated with ECMO support were identified, with a survival rate of 39.7% (77/194). The authors conclude that the use of ECMO in major aortic surgery or dissection is justified, despite that there is no compelling evidence for or against the use of ECMO in this patient population. 

Source: YouTube
Author(s): Diego Gonzalez Rivas

Surely there can be no better example of how healthcare can break down all boundaries between people than this? 

While Trump and Iran ramp up tensions in the region, Diego Gonzalez Rivas makes good on his promise to go and do a materclass in Kurdistan in Iraq. What a fantastic example of putting people and patients ahead of politics! 

Diego, you should be put in charge of the United Nations. It looks like even in Iraq there are excellent surgeons and a need for the best surgery available for lung cancer. 

Source: World Journal for Pediatric and Congenital Heart Surgery
Author(s): Joseph A. Dearani

In this editorial, Dr Joseph Dearani, Chair of the Department of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota, addresses the important and timely subject of outcomes measurement, and of transparency and public reporting of cardiac surgery outcomes.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Saadallah Tamer, Stefano Mastrobuoni, Michel van Dyck, Emiliano Navarra, Xavier Bollen, Alain Poncelet, Philippe Noirhomme, Parla Astarci, Gebrine El Khoury, Laurent de Kerchove

The aim of this study was to investigate the role of free margin length and geometric height in normal aortic valves and aortic dilatation. 

This study prospectively acquired these measurements within 132 patients, who were operated on for aortic insufficiency, aortic dilatation, endocarditis, or fibroelastoma. Patients with aortic dilatation and leaflet prolapse showed significantly larger free margin length and geometric height compared to patients with normal aortic valve function.

The authors concluded that these measurements provide a new point of view into the pathomorphology of the aortic valve and might support new aortic valve repair methods.

Source: CA: A Cancer Journal for Clinicians
Author(s): Rebecca L. Siegel MPH Kimberly D. Miller MPH Ahmedin Jemal DVM, PhD

Declines in US annual lung cancer mortality rates of 5% for men and 4% for women led improvements in overall cancer mortality rates in the latest update from the American Cancer Society. This is likely linked to efforts at decreasing tobacco use, improved screening, and newer systemic therapies.

Source: The Lancet
Author(s): Timo Mäkikallio, Niels R Holm, Mitchell Lindsay, Mark S Spence, Andrejs Erglis, Ian B A Menown, Thor Trovik, Markku Eskola, Hannu Romppanen, Thomas Kellerth, Jan Ravkilde, Lisette O Jensen, Gintaras Kalinauskas, Rikard B A Linder, Markku Pentikainen, Anders Hervold, Adrian Banning, Azfar Zaman, Jamen Cotton, Erlend Eriksen, Sulev Margus, Henrik T Sørensen, Per H Nielsen, Matti Niemelä, Kari Kervinen, Jens F Lassen, Michael Maeng, Keith Oldroyd, Geoff Berg, Simon J Walsh, Colm G Hanratty, Indulis Kumsars, Peteris Stradins, Terje K Steigen, Ole Fröbert, Alastair N J Graham, Petter C Endresen, Matthias Corbascio, Olli Kajander, Uday Trivedi, Juha Hartikainen, Vesa Anttila, David Hildick-Smith, Leif Thuesen, Evald H Christiansen, for the NOBLE study investigators

''CABG was significantly better than PCI (p=0·0066........''

Source: Lung Cancer
Author(s): Paul Pinskya, David S. Gieradab

Benign-appearing lung nodules identified on screening CTs are associated with an increased risk of lung cancer diagnosis 4 to 8 and 8 to 11 years after the scan (RRs 1.9 and 1.6, respectively).

Source: The New England Journal of Medicine
Author(s): Duk-Hyun Kang, Sung-Ji Park, Seung-Ah Lee, Sahmin Lee, Dae-Hee Kim, Hyung-Kwan Kim, Sung-Cheol Yun, Ph.D., Geu-Ru Hong, Jong-Min Song, Cheol-Hyun Chung, Jae-Kwan Song, Jae-Won Lee, Seung-Woo Park

A medium size RCTwith encouraging surgical outcomes in the era of TAVI expansion.....

Source: JAMA
Author(s): Rahul Bhatnagar, Hania E. G. Piotrowska, Magda Laskawiec-Szkonter, Brennan C. Kahan, Ramon Luengo-Fernandez, Justin C. T. Pepperell, Matthew D. Evison, Jayne Holme, Mohamed Al-Aloul, Ioannis Psallidas, Wei Shen Lim, Kevin G. Blyth, Mark E. Roberts, Giles Cox, Nicola J. Downer, Jurgen Herre, Pasupathy Sivasothy, Daniel Menzies, Mohammed Munavvar, Moe M. Kyi, Liju Ahmed, Alex G. West, Richard N. Harrison, Benjamin Prudon, Gihan Hettiarachchi, Biswajit Chakrabarti, Ajikumar Kavidasan, Benjamin P. Sutton, Natalie J. Zahan-Evans, Jack L. Quaddy, Anthony J. Edey, Amelia O. Clive, Steven P. Walker, Matthew H. R. Little, Xue W. Mei, John E. Harvey, Clare E. Hooper, Helen E. Davies, Mark Slade, Merle Sivier, Robert F. Miller, Najib M. Rahman, Nick A. Maskell

In this randomized trial including 330 pts with MPE, talc slurry and VATS talc insufflation under local anesthesia had similar failure rates (24% vs 22%) at 90 days.

Pages